Sowell Financial Services LLC Vir Biotechnology, Inc. Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$38.75 - $51.0 $61,883 - $81,447	-1,597 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$26.34 - $83.07 $30,844 - $97,274	-1,171 Reduced 42.3%	1,597 $66,000
Q4 2020 Jan 13, 2021	BUY	$25.51 - $43.38 $5,765 - $9,803	226 Added 8.89%	2,768 $74,000
Q3 2020 Nov 12, 2020	BUY	$28.28 - $53.6 $11,877 - $22,512	420 Added 19.79%	2,542 $87,000
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $59,182 - $101,558	2,122 New	2,122 $87,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.04B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.